A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases

Eram, Mohammad S.; Shen, Yudao; Szewczyk, Magdalena M.; Wu, Hong; Senisterra, Guillermo; Li, Fengling; Butler, Kyle V.; Kaniskan, H. Ümit; Speed, Brandon A.; dela Seña, Carlo; Dong, Aiping; Zeng, Hong; Schapira, Matthieu; Brown, Peter J.; Arrowsmith, Cheryl H.; Barsyte-Lovejoy, Dalia; Liu, Jing; Vedadi, Masoud; Jin, Jian

doi:10.1021/acschembio.5b00839

A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases

Journal Article · Tue Nov 24 00:00:00 EST 2015 · ACS Chemical Biology

DOI:https://doi.org/10.1021/acschembio.5b00839· OSTI ID:1243125

Eram, Mohammad S. ^[1]; Shen, Yudao ^[2]; Szewczyk, Magdalena M. ^[1]; Wu, Hong ^[1]; Senisterra, Guillermo ^[1]; Li, Fengling ^[1]; Butler, Kyle V. ^[2]; Kaniskan, H. Ümit ^[2]; Speed, Brandon A. ^[2]; dela Seña, Carlo ^[1]; Dong, Aiping ^[1]; Zeng, Hong ^[1]; Schapira, Matthieu ^[1]; Brown, Peter J. ^[1]; Arrowsmith, Cheryl H. ^[1]; Barsyte-Lovejoy, Dalia ^[1]; Liu, Jing ^[2]; Vedadi, Masoud ^[1]; Jin, Jian ^[2]

Univ. of Toronto, ON (Canada)
Icahn School of Medicine at Mount Sinai, New York, NY (United States)

Protein arginine methyltransferases (PRMTs) play a crucial role in a variety of biological processes. Overexpression of PRMTs has been implicated in various human diseases including cancer. Consequently, selective small-molecule inhibitors of PRMTs have been pursued by both academia and the pharmaceutical industry as chemical tools for testing biological and therapeutic hypotheses. PRMTs are divided into three categories: type I PRMTs which catalyze mono- and asymmetric dimethylation of arginine residues, type II PRMTs which catalyze mono- and symmetric dimethylation of arginine residues, and type III PRMT which catalyzes only monomethylation of arginine residues. Here, we report the discovery of a potent, selective, and cell-active inhibitor of human type I PRMTs, MS023, and characterization of this inhibitor in a battery of biochemical, biophysical, and cellular assays. MS023 displayed high potency for type I PRMTs including PRMT1, -3, -4, -6, and -8 but was completely inactive against type II and type III PRMTs, protein lysine methyltransferases and DNA methyltransferases. A crystal structure of PRMT6 in complex with MS023 revealed that MS023 binds the substrate binding site. MS023 potently decreased cellular levels of histone arginine asymmetric dimethylation. It also reduced global levels of arginine asymmetric dimethylation and concurrently increased levels of arginine monomethylation and symmetric dimethylation in cells. We also developed MS094, a close analog of MS023, which was inactive in biochemical and cellular assays, as a negative control for chemical biology studies. In conclusion, MS023 and MS094 are useful chemical tools for investigating the role of type I PRMTs in health and disease.

View Accepted Manuscript (DOE)

Research Organization:: Argonne National Laboratory (ANL), Argonne, IL (United States)

Sponsoring Organization:: AbbVie, Bayer Pharma AG; Boehringer Ingelheim; Canada Foundation for Innovation; Eshelman Inst. for Innovation; Genome Canada; Innovative Medicines Initiative (EU/EFPIA); Janssen, Merck & Co.; Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer; São Paulo Research Foundation-FAPESP; Takeda; U.S. National Inst. of Health; ULTRA-DD; Wellcome Trust

OSTI ID:: 1243125

Journal Information:: ACS Chemical Biology, Journal Name: ACS Chemical Biology Journal Issue: 3 Vol. 11; ISSN 1554-8929

Publisher:: American Chemical Society (ACS)Copyright Statement

Country of Publication:: United States

Language:: ENGLISH

References (53)

A Potent, Selective and Cell-Active Allosteric Inhibitor of Protein Arginine Methyltransferase 3 (PRMT3) Kaniskan, H. Ümit; Szewczyk, Magdalena M.; Yu, Zhengtian Angewandte Chemie International Edition, Vol. 54, Issue 17 https://doi.org/10.1002/anie.201412154	journal	February 2015
Design, Synthesis and Biological Evaluation of Carboxy Analogues of Arginine Methyltransferase Inhibitor 1 (AMI-1) Castellano, Sabrina; Milite, Ciro; Ragno, Rino ChemMedChem, Vol. 5, Issue 3 https://doi.org/10.1002/cmdc.200900459	journal	February 2010
Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen-independent status Hong, Heng; Kao, Chinghai; Jeng, Meei-Huey Cancer, Vol. 101, Issue 1 https://doi.org/10.1002/cncr.20327	journal	January 2004
Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers Yoshimatsu, Masanori; Toyokawa, Gouji; Hayami, Shinya International Journal of Cancer, Vol. 128, Issue 3 https://doi.org/10.1002/ijc.25366	journal	November 2010
Distribution of NG, NG-dimethylarginine in nuclear protein fractions Boffa, L. C.; Karn, J.; Vidali, G. Biochemical and Biophysical Research Communications, Vol. 74, Issue 3 https://doi.org/10.1016/0006-291X(77)91613-8	journal	February 1977
Methylation of histone H4 at arginine 3 occurs in vivo and is mediated by the nuclear receptor coactivator PRMT1 Strahl, Brian D.; Briggs, Scott D.; Brame, Cynthia J. Current Biology, Vol. 11, Issue 12 https://doi.org/10.1016/S0960-9822(01)00294-9	journal	June 2001
CARM1 and PRMT1 are dysregulated in lung cancer without hierarchical features Elakoum, Rania; Gauchotte, Guillaume; Oussalah, Abderrahim Biochimie, Vol. 97 https://doi.org/10.1016/j.biochi.2013.10.021	journal	February 2014
Pyrazole inhibitors of coactivator associated arginine methyltransferase 1 (CARM1) Purandare, Ashok V.; Chen, Zhong; Huynh, Tram Bioorganic & Medicinal Chemistry Letters, Vol. 18, Issue 15 https://doi.org/10.1016/j.bmcl.2008.06.026	journal	August 2008
N-Benzyl-1-heteroaryl-3-(trifluoromethyl)-1H-pyrazole-5-carboxamides as inhibitors of co-activator associated arginine methyltransferase 1 (CARM1) Allan, Martin; Manku, Sukhdev; Therrien, Eric Bioorganic & Medicinal Chemistry Letters, Vol. 19, Issue 4 https://doi.org/10.1016/j.bmcl.2008.12.075	journal	February 2009
Optimization of pyrazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1) Huynh, Tram; Chen, Zhong; Pang, Suhong Bioorganic & Medicinal Chemistry Letters, Vol. 19, Issue 11 https://doi.org/10.1016/j.bmcl.2009.04.075	journal	June 2009
Benzo[d]imidazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1)—Hit to Lead studies Wan, Honghe; Huynh, Tram; Pang, Suhong Bioorganic & Medicinal Chemistry Letters, Vol. 19, Issue 17 https://doi.org/10.1016/j.bmcl.2009.07.040	journal	September 2009
1,2-Diamines as inhibitors of co-activator associated arginine methyltransferase 1 (CARM1) Therrien, Eric; Larouche, Guillaume; Manku, Sukhdev Bioorganic & Medicinal Chemistry Letters, Vol. 19, Issue 23 https://doi.org/10.1016/j.bmcl.2009.09.110	journal	December 2009
CARM1 Methylates Chromatin Remodeling Factor BAF155 to Enhance Tumor Progression and Metastasis Wang, Lu; Zhao, Zibo; Meyer, Mark B. Cancer Cell, Vol. 25, Issue 1 https://doi.org/10.1016/j.ccr.2013.12.007	journal	January 2014
Deregulation of protein methylation in melanoma Limm, Katharina; Ott, Corinna; Wallner, Susanne European Journal of Cancer, Vol. 49, Issue 6 https://doi.org/10.1016/j.ejca.2012.11.026	journal	April 2013
Arginine Methylation Bedford, Mark T.; Richard, Stéphane Molecular Cell, Vol. 18, Issue 3 https://doi.org/10.1016/j.molcel.2005.04.003	journal	April 2005
Protein Arginine Methylation in Mammals: Who, What, and Why Bedford, Mark T.; Clarke, Steven G. Molecular Cell, Vol. 33, Issue 1 https://doi.org/10.1016/j.molcel.2008.12.013	journal	January 2009
Role of the PRMT–DDAH–ADMA axis in the regulation of endothelial nitric oxide production Pope, Arthur J.; Karuppiah, Kanchana; Cardounel, Arturo J. Pharmacological Research, Vol. 60, Issue 6 https://doi.org/10.1016/j.phrs.2009.07.016	journal	December 2009
An Allosteric Inhibitor of Protein Arginine Methyltransferase 3 Siarheyeva, Alena; Senisterra, Guillermo; Allali-Hassani, Abdellah Structure, Vol. 20, Issue 8 https://doi.org/10.1016/j.str.2012.06.001	journal	August 2012
Aryl Pyrazoles as Potent Inhibitors of Arginine Methyltransferases: Identification of the First PRMT6 Tool Compound Mitchell, Lorna H.; Drew, Allison E.; Ribich, Scott A. ACS Medicinal Chemistry Letters, Vol. 6, Issue 6 https://doi.org/10.1021/acsmedchemlett.5b00071	journal	April 2015
Novel Oxindole Sulfonamides and Sulfamides: EPZ031686, the First Orally Bioavailable Small Molecule SMYD3 Inhibitor Mitchell, Lorna H.; Boriack-Sjodin, P. Ann; Smith, Sherri ACS Medicinal Chemistry Letters, Vol. 7, Issue 2 https://doi.org/10.1021/acsmedchemlett.5b00272	journal	August 2015
Chemical Probes of Histone Lysine Methyltransferases Kaniskan, H. Ümit; Jin, Jian ACS Chemical Biology, Vol. 10, Issue 1 https://doi.org/10.1021/cb500785t	journal	November 2014
Exploiting an Allosteric Binding Site of PRMT3 Yields Potent and Selective Inhibitors Liu, Feng; Li, Fengling; Ma, Anqi Journal of Medicinal Chemistry, Vol. 56, Issue 5 https://doi.org/10.1021/jm3018332	journal	February 2013
Selective Inhibitors of Protein Methyltransferases Kaniskan, H. Ümit; Konze, Kyle D.; Jin, Jian Journal of Medicinal Chemistry, Vol. 58, Issue 4 https://doi.org/10.1021/jm501234a	journal	December 2014
Discovery of a Dual PRMT5–PRMT7 Inhibitor Smil, David; Eram, Mohammad S.; Li, Fengling ACS Medicinal Chemistry Letters, Vol. 6, Issue 4 https://doi.org/10.1021/ml500467h	journal	February 2015
Global histone modification patterns predict risk of prostate cancer recurrence Seligson, David B.; Horvath, Steve; Shi, Tao Nature, Vol. 435, Issue 7046 https://doi.org/10.1038/nature03672	journal	June 2005
Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are mutually exclusive Guccione, Ernesto; Bassi, Christian; Casadio, Fabio Nature, Vol. 449, Issue 7164 https://doi.org/10.1038/nature06166	journal	September 2007
A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models Chan-Penebre, Elayne; Kuplast, Kristy G.; Majer, Christina R. Nature Chemical Biology, Vol. 11, Issue 6 https://doi.org/10.1038/nchembio.1810	journal	April 2015
The art of the chemical probe Frye, Stephen V. Nature Chemical Biology, Vol. 6, Issue 3 https://doi.org/10.1038/nchembio.296	journal	March 2010
PRMT9 is a Type II methyltransferase that methylates the splicing factor SAP145 Yang, Yanzhong; Hadjikyriacou, Andrea; Xia, Zheng Nature Communications, Vol. 6, Issue 1 https://doi.org/10.1038/ncomms7428	journal	March 2015
Protein arginine methyltransferases and cancer Yang, Yanzhong; Bedford, Mark T. Nature Reviews Cancer, Vol. 13, Issue 1 https://doi.org/10.1038/nrc3409	journal	December 2012
Deciphering arginine methylation: Tudor tells the tale Chen, Chen; Nott, Timothy J.; Jin, Jing Nature Reviews Molecular Cell Biology, Vol. 12, Issue 10 https://doi.org/10.1038/nrm3185	journal	September 2011
Structural basis for dimethylarginine recognition by the Tudor domains of human SMN and SPF30 proteins Tripsianes, Konstantinos; Madl, Tobias; Machyna, Martin Nature Structural & Molecular Biology, Vol. 18, Issue 12 https://doi.org/10.1038/nsmb.2185	journal	November 2011
The PRMT1 gene expression pattern in colon cancer Mathioudaki, K.; Papadokostopoulou, A.; Scorilas, A. British Journal of Cancer, Vol. 99, Issue 12 https://doi.org/10.1038/sj.bjc.6604807	journal	December 2008
Loss of the major Type I arginine methyltransferase PRMT1 causes substrate scavenging by other PRMTs Dhar, Surbhi; Vemulapalli, Vidyasiri; Patananan, Alexander N. Scientific Reports, Vol. 3, Issue 1 https://doi.org/10.1038/srep01311	journal	February 2013
Structural biology and chemistry of protein arginine methyltransferases Schapira, Matthieu; Ferreira de Freitas, Renato MedChemComm, Vol. 5, Issue 12 https://doi.org/10.1039/C4MD00269E	journal	January 2014
Structural basis for CARM1 inhibition by indole and pyrazole inhibitors Sack, John S.; Thieffine, Sandrine; Bandiera, Tiziano Biochemical Journal, Vol. 436, Issue 2 https://doi.org/10.1042/BJ20102161	journal	May 2011
Coactivator-associated arginine methyltransferase 1 (CARM1) is a positive regulator of the Cyclin E1 gene El Messaoudi, S.; Fabbrizio, E.; Rodriguez, C. Proceedings of the National Academy of Sciences, Vol. 103, Issue 36 https://doi.org/10.1073/pnas.0605692103	journal	August 2006
(R)-PFI-2 is a potent and selective inhibitor of SETD7 methyltransferase activity in cells Barsyte-Lovejoy, D.; Li, F.; Oudhoff, M. J. Proceedings of the National Academy of Sciences, Vol. 111, Issue 35 https://doi.org/10.1073/pnas.1407358111	journal	August 2014
IC50-to-Ki: a web-based tool for converting IC50 to Ki values for inhibitors of enzyme activity and ligand binding Cer, R. Z.; Mudunuri, U.; Stephens, R. Nucleic Acids Research, Vol. 37, Issue Web Server https://doi.org/10.1093/nar/gkp253	journal	April 2009
PRMT5 is required for cell-cycle progression and p53 tumor suppressor function Scoumanne, A.; Zhang, J.; Chen, X. Nucleic Acids Research, Vol. 37, Issue 15 https://doi.org/10.1093/nar/gkp516	journal	June 2009
The arginine methyltransferase PRMT6 regulates cell proliferation and senescence through transcriptional repression of tumor suppressor genes Stein, C.; Riedl, S.; Ruthnick, D. Nucleic Acids Research, Vol. 40, Issue 19 https://doi.org/10.1093/nar/gks767	journal	August 2012
p53-Independent regulation of p21Waf1/Cip1 expression and senescence by PRMT6 Phalke, Sameer; Mzoughi, Slim; Bezzi, Marco Nucleic Acids Research, Vol. 40, Issue 19 https://doi.org/10.1093/nar/gks858	journal	September 2012
Non-Competitive Inhibition by Active Site Binders: Non-Competitive Inhibition by Active Site Binders Blat, Yuval Chemical Biology & Drug Design, Vol. 75, Issue 6 https://doi.org/10.1111/j.1747-0285.2010.00972.x	journal	March 2010
Methylation of Histone H4 at Arginine 3 Facilitating Transcriptional Activation by Nuclear Hormone Receptor Wang, H. Science, Vol. 293, Issue 5531 https://doi.org/10.1126/science.1060781	journal	May 2001
DDAH gene and cardiovascular risk Valkonen, Veli-Pekka; Tuomainen, Tomi-Pekka; Laaksonen, Reijo Vascular Medicine, Vol. 10, Issue 1_suppl https://doi.org/10.1177/1358836X0501000107	journal	July 2005
PRMT1 interacts with AML1-ETO to promote its transcriptional activation and progenitor cell proliferative potential Shia, Wei-Jong; Okumura, Akiko J.; Yan, Ming Blood, Vol. 119, Issue 21 https://doi.org/10.1182/blood-2011-04-347476	journal	May 2012
Arginine methyltransferase CARM1/PRMT4 regulates endochondral ossification Ito, Tatsuo; Yadav, Neelu; Lee, Jaeho BMC Developmental Biology, Vol. 9, Issue 1 https://doi.org/10.1186/1471-213X-9-47	journal	January 2009
Differential CARM1 expression in prostate and colorectal cancers Kim, Young-Rang; Lee, Byung Kook; Park, Ra-Young BMC Cancer, Vol. 10, Issue 1 https://doi.org/10.1186/1471-2407-10-197	journal	May 2010
Deregulated expression of selected histone methylases and demethylases in prostate carcinoma Vieira, Filipa Quintela; Costa-Pinheiro, Pedro; Ramalho-Carvalho, João Endocrine-Related Cancer, Vol. 21, Issue 1 https://doi.org/10.1530/ERC-13-0375	journal	November 2013
Association of asymmetric dimethylarginine with sickle cell disease-related pulmonary hypertension Landburg, P. P.; Teerlink, T.; van Beers, E. J. Haematologica, Vol. 93, Issue 9 https://doi.org/10.3324/haematol.12928	journal	September 2008
Alternatively spliced protein arginine methyltransferase 1 isoform PRMT1v2 promotes the survival and invasiveness of breast cancer cells Baldwin, R. Mitchell; Morettin, Alan; Paris, Genevieve Cell Cycle, Vol. 11, Issue 24 https://doi.org/10.4161/cc.22871	journal	December 2012
Protein arginine methylation of non-histone proteins and its role in diseases Wei, Han; Mundade, Rasika; Lange, Kevin Cell Cycle, Vol. 13, Issue 1 https://doi.org/10.4161/cc.27353	journal	November 2013
The role of protein arginine-methyltransferase 1 in gliomagenesis Wang, Shan; Tan, Xiaochao; Yang, Bin BMB Reports, Vol. 45, Issue 8 https://doi.org/10.5483/BMBRep.2012.45.8.022	journal	August 2012

Cited By (36)

Inhibitors of Protein Methyltransferases and Demethylases Kaniskan, H. Ümit; Martini, Michael L.; Jin, Jian Chemical Reviews, Vol. 118, Issue 3 https://doi.org/10.1021/acs.chemrev.6b00801	journal	March 2017
Benzoisoquinolinediones as Potent and Selective Inhibitors of BRPF2 and TAF1/TAF1L Bromodomains Bouché, Léa; Christ, Clara D.; Siegel, Stephan Journal of Medicinal Chemistry, Vol. 60, Issue 9 https://doi.org/10.1021/acs.jmedchem.7b00306	journal	May 2017
GFI1 facilitates efficient DNA repair by regulating PRMT1 dependent methylation of MRE11 and 53BP1 Vadnais, Charles; Chen, Riyan; Fraszczak, Jennifer Nature Communications, Vol. 9, Issue 1 https://doi.org/10.1038/s41467-018-03817-5	journal	April 2018
PRMT2 links histone H3R8 asymmetric dimethylation to oncogenic activation and tumorigenesis of glioblastoma Dong, Feng; Li, Qian; Yang, Chao Nature Communications, Vol. 9, Issue 1 https://doi.org/10.1038/s41467-018-06968-7	journal	October 2018
A chemical biology toolbox to study protein methyltransferases and epigenetic signaling Scheer, Sebastian; Ackloo, Suzanne; Medina, Tiago S. Nature Communications, Vol. 10, Issue 1 https://doi.org/10.1038/s41467-018-07905-4	journal	January 2019
PRMT5 regulates IRES-dependent translation via methylation of hnRNP A1 Gao, Guozhen; Dhar, Surbhi; Bedford, Mark T. Nucleic Acids Research https://doi.org/10.1093/nar/gkw1367	journal	January 2017
Arginine methylation of the C-terminus RGG motif promotes TOP3B topoisomerase activity and stress granule localization Huang, Lifeng; Wang, Zhihao; Narayanan, Nithya Nucleic Acids Research, Vol. 46, Issue 6 https://doi.org/10.1093/nar/gky103	journal	February 2018
Protein methyltransferase inhibitors as precision cancer therapeutics: a decade of discovery Copeland, Robert A. Philosophical Transactions of the Royal Society B: Biological Sciences, Vol. 373, Issue 1748 https://doi.org/10.1098/rstb.2017.0080	journal	April 2018
Epigenetics in ovarian cancer: premise, properties, and perspectives Yang, Qilian; Yang, Yuqing; Zhou, Nianxin Molecular Cancer, Vol. 17, Issue 1 https://doi.org/10.1186/s12943-018-0855-4	journal	July 2018
Targeting histone methylation for cancer therapy: enzymes, inhibitors, biological activity and perspectives Song, Yongcheng; Wu, Fangrui; Wu, Jingyu Journal of Hematology & Oncology, Vol. 9, Issue 1 https://doi.org/10.1186/s13045-016-0279-9	journal	June 2016
TP-064, a potent and selective small molecule inhibitor of PRMT4 for multiple myeloma Nakayama, Kazuhide; Szewczyk, Magdalena M.; Sena, Carlo dela Oncotarget, Vol. 9, Issue 26 https://doi.org/10.18632/oncotarget.24883	journal	March 2018
The Development of Tetrazole Derivatives as Protein Arginine Methyltransferase I (PRMT I) Inhibitors No authors listed International Journal of Molecular Sciences, Vol. 20, Issue 15 https://doi.org/10.3390/ijms20153840	journal	August 2019
Methyltransferase Inhibitors: Competing with, or Exploiting the Bound Cofactor Ferreira de Freitas, Renato; Ivanochko, Danton; Schapira, Matthieu Molecules, Vol. 24, Issue 24 https://doi.org/10.3390/molecules24244492	journal	December 2019
Inhibiting Arginine Methylation as a Tool to Investigate Cross-Talk with Methylation and Acetylation Post-Translational Modifications in a Glioblastoma Cell Line Samuel, Sabrina; Marsden, Alistair; Deepak, Srihari Proteomes, Vol. 6, Issue 4 https://doi.org/10.3390/proteomes6040044	journal	October 2018
Mechanisms and Inhibitors of Histone Arginine Methylation Fulton, Melody D.; Brown, Tyler; Zheng, Y. George The Chemical Record, Vol. 18, Issue 12 https://doi.org/10.1002/tcr.201800082	journal	August 2018
Targeting protein methylation: from chemical tools to precision medicines Dilworth, David; Barsyte-Lovejoy, Dalia Cellular and Molecular Life Sciences, Vol. 76, Issue 15 https://doi.org/10.1007/s00018-019-03147-9	journal	May 2019
Protein Arginine Methyltransferases in Cardiovascular and Neuronal Function Couto e. Silva, Alexandre; Wu, Celeste Yin-Chieh; Citadin, Cristiane T. Molecular Neurobiology, Vol. 57, Issue 3 https://doi.org/10.1007/s12035-019-01850-z	journal	December 2019
A chemical probe toolbox for dissecting the cancer epigenome Shortt, Jake; Ott, Christopher J.; Johnstone, Ricky W. Nature Reviews Cancer, Vol. 17, Issue 3 https://doi.org/10.1038/nrc.2016.148	journal	February 2017
The regulation, functions and clinical relevance of arginine methylation Guccione, Ernesto; Richard, Stéphane Nature Reviews Molecular Cell Biology, Vol. 20, Issue 10 https://doi.org/10.1038/s41580-019-0155-x	journal	July 2019
Design and synthesis of selective, small molecule inhibitors of coactivator-associated arginine methyltransferase 1 (CARM1) Kaniskan, H. Ü.; Eram, M. S.; Liu, J. MedChemComm, Vol. 7, Issue 9 https://doi.org/10.1039/c6md00342g	journal	January 2016
Discovery of decamidine as a new and potent PRMT1 inhibitor Zhang, Jing; Qian, Kun; Yan, Chunli MedChemComm, Vol. 8, Issue 2 https://doi.org/10.1039/c6md00573j	journal	January 2017
Structural basis of arginine asymmetrical dimethylation by PRMT6 Wu, Hong; Zheng, Weihong; Eram, Mohammad S. Biochemical Journal, Vol. 473, Issue 19 https://doi.org/10.1042/bcj20160537	journal	September 2016
Epigenetic control via allosteric regulation of mammalian protein arginine methyltransferases Jain, Kanishk; Jin, Cyrus Y.; Clarke, Steven G. Proceedings of the National Academy of Sciences, Vol. 114, Issue 38 https://doi.org/10.1073/pnas.1706978114	journal	September 2017
Arginine Demethylation of G3BP1 Promotes Stress Granule Assembly Tsai, Wei-Chih; Gayatri, Sitaram; Reineke, Lucas C. Journal of Biological Chemistry, Vol. 291, Issue 43 https://doi.org/10.1074/jbc.m116.739573	journal	September 2016
A patent review of arginine methyltransferase inhibitors (2010–2018) Li, Xiao; Wang, Chen; Jiang, Hao Expert Opinion on Therapeutic Patents, Vol. 29, Issue 2 https://doi.org/10.1080/13543776.2019.1567711	journal	January 2019
Recent advances in targeting protein arginine methyltransferase enzymes in cancer therapy Smith, Emily; Zhou, Wei; Shindiapina, Polina Expert Opinion on Therapeutic Targets, Vol. 22, Issue 6 https://doi.org/10.1080/14728222.2018.1474203	journal	May 2018
The story of protein arginine methylation: characterization, regulation, and function Peng, Chao; Wong, Catherine CL Expert Review of Proteomics, Vol. 14, Issue 2 https://doi.org/10.1080/14789450.2017.1275573	journal	January 2017
A Chemical Biology Toolbox for the Study of Protein Methyltransferases and Epigenetic Signaling Scheer, Sebastian; Ackloo, Suzanne; Medina, Tiago S. BioRxiv https://doi.org/10.1101/260638	posted_content	February 2018
PRMT1-mediated methylation of the Large Drosha Complex regulates microRNA biogenesis Spadotto, Valeria; Giambruno, Roberto; Massignani, Enrico BioRxiv https://doi.org/10.1101/466813	posted_content	November 2018
Pharmacological inhibition of PRMT7 links arginine monomethylation to the cellular stress responses Szewczyk, Magdalena M.; Ishikawa, Yoshinori; Organ, Shawna Nature Communications https://doi.org/10.1101/503136	journal	March 2019
Smad6 Methylation Represses NFκB Activation and Periodontal Inflammation Zhang, T.; Wu, J.; Ungvijanpunya, N. Journal of Dental Research, Vol. 97, Issue 7 https://doi.org/10.1177/0022034518755688	journal	February 2018
PRMT1-mediated FLT3 arginine methylation promotes maintenance of FLT3-ITD+ acute myeloid leukemia He, Xin; Zhu, Yinghui; Lin, Yi-Chun Blood, Vol. 134, Issue 6 https://doi.org/10.1182/blood.2019001282	journal	August 2019
Proteome-wide identification of arginine methylation in colorectal cancer tissues from patients Lim, Yongchul; Lee, Ju Yeon; Ha, Su Jin Proteome Science, Vol. 18, Issue 1 https://doi.org/10.1186/s12953-020-00162-8	journal	May 2020
Protein arginine methylation: an emerging regulator of the cell cycle Raposo, Anita E.; Piller, Sabine C. Cell Division, Vol. 13, Issue 1 https://doi.org/10.1186/s13008-018-0036-2	journal	March 2018
BindingDB Entry 7156: A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases. No authors listed BindingDB https://doi.org/10.7270/q2765d4h	dataset	January 2016
BindingDB Entry 5298: Cloning, expression, and pharmacological characterization of a novel human histamine receptor. No authors listed BindingDB https://doi.org/10.7270/q2z899zr	dataset	January 2012

Similar Records

Computational Study of Symmetric Methylation on Histone Arginine Catalyzed by Protein Arginine Methyltransferase PRMT5 through QM/MM MD and Free Energy Simulations

Journal Article · Wed Dec 31 19:00:00 EST 2014 · Molecules · OSTI ID:1336584

Discovery of Potent and Selective Allosteric Inhibitors of Protein Arginine Methyltransferase 3 (PRMT3)

Journal Article · Thu Dec 14 19:00:00 EST 2017 · Journal of Medicinal Chemistry · OSTI ID:1570752

Pharmacological inhibition of PRMT7 links arginine monomethylation to the cellular stress response

Journal Article · Wed May 13 20:00:00 EDT 2020 · Nature Communications · OSTI ID:1660996

Related Subjects

37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CHEMISTRY
59 BASIC BIOLOGICAL SCIENCES

A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases

Citation Formats

References (53)

Cited By (36)

Similar Records

Related Subjects